Home / Idelalisib / United States
US ATC L01EM01 · updated 2 Nov 2026
Idelalisib shortage in United States
Is there an Idelalisib shortage in United States?
Yes. As of 2 Nov 2026, 2 Idelalisib products are reported short in United States, the first since 7 Apr 2026. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Zydelig, Tablet, 100 mg (NDC 61958-1701-1) discontinuation | Gilead Sciences, Inc. | 7 Apr 2026 | not given | Not stated |
| US | Zydelig, Tablet, 150 mg (NDC 61958-1702-1) discontinuation | Gilead Sciences, Inc. | 7 Apr 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).